VIP and infection: VIP treatment for day 5–10 alleviated the reduction in mitochondrial phosphorylation capacity for both the day 10 (-51% to -8%, p<0.05, Fig 5D) and day 14 (-61% to -17%, p<0.05, Fig 5D) post infection groups.